22:53 , Feb 8, 2018 |  BC Innovations  |  Translation in Brief

Diverging pathways

Results from a National Cancer Institute study could explain disparities in treatment outcomes for African-Americans, who have the highest lung cancer incidence and mortality rates of any racial group. The study, published in Clinical Cancer Research...
07:00 , Apr 1, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer MicroRNA-10b (miR-10b) In vitro and mouse studies suggest that antagonizing miR-10b could help prevent breast...
08:00 , Feb 16, 2009 |  BC Week In Review  |  Clinical News

Rosetta Genomics preclinical data

In mouse xenograft models of human liver cancer, ASO-MOE-191 significantly decreased miR-191 in the liver and in the tumor at day 15 (p=0.005 and p=0.001, respectively). The chemically modified antisense oligonucleotide targeting microRNA-191...